DE69127619D1 - Ketanserin enthaltende Augentropfen zur Behandlung von intraokularem Druck - Google Patents

Ketanserin enthaltende Augentropfen zur Behandlung von intraokularem Druck

Info

Publication number
DE69127619D1
DE69127619D1 DE69127619T DE69127619T DE69127619D1 DE 69127619 D1 DE69127619 D1 DE 69127619D1 DE 69127619 T DE69127619 T DE 69127619T DE 69127619 T DE69127619 T DE 69127619T DE 69127619 D1 DE69127619 D1 DE 69127619D1
Authority
DE
Germany
Prior art keywords
optionally
ketanserin
inhibitors
combinations
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69127619T
Other languages
English (en)
Inventor
Ciro Costagliola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69127619D1 publication Critical patent/DE69127619D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Devices For Medical Bathing And Washing (AREA)
DE69127619T 1991-07-12 1991-12-20 Ketanserin enthaltende Augentropfen zur Behandlung von intraokularem Druck Expired - Lifetime DE69127619D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM910519A IT1249678B (it) 1991-07-12 1991-07-12 Collirio per il trattamento della ipertensione oculare

Publications (1)

Publication Number Publication Date
DE69127619D1 true DE69127619D1 (de) 1997-10-16

Family

ID=11400263

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69127619T Expired - Lifetime DE69127619D1 (de) 1991-07-12 1991-12-20 Ketanserin enthaltende Augentropfen zur Behandlung von intraokularem Druck

Country Status (5)

Country Link
EP (1) EP0522226B1 (de)
JP (1) JPH0525047A (de)
AT (1) ATE157872T1 (de)
DE (1) DE69127619D1 (de)
IT (1) IT1249678B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0813878B1 (de) * 1996-06-17 2002-02-06 Mitsubishi Chemical Corporation Mittel zur Beschleunigung des Tränenflusses enthaltend einen Serotonin-Liganden, insbesondere Aminoalkoxybibenzyle
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
JP2002526443A (ja) 1998-09-18 2002-08-20 アルコン ラボラトリーズ， インコーポレーテッド 緑内障治療用セロトニン作動性５ｈｔ２作用物質
JP2005511764A (ja) 2001-12-14 2005-04-28 アルコン，インコーポレイテッド 緑内障の処置のためのアミノアルキルベンゾフラン−５−オール化合物
ES2281666T3 (es) 2002-07-19 2007-10-01 Biovitrum Ab Novedosos derivados de piperazinil-pirazinona para el tratamiento de los desordenes relacionados con el receptor 5-ht2a.
US9421175B2 (en) 2004-03-17 2016-08-23 Lars Michael Larsen Prevention of retinopathy by inhibition of the visual cycle
IT201600072000A1 (it) * 2016-07-11 2018-01-11 Luigi Ambrosone Collirio a base di liposomi e suo uso per la valutazione in vivo dell'efficacia farmacologica della terapia medica e chirurgica anti-glaucoma
SE2250051A1 (en) * 2022-01-20 2023-07-21 Amidea Sweden Ab New pharmaceutical composition and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0268309B1 (de) * 1986-09-22 1996-12-11 Janssen Pharmaceutica N.V. Serotonin-Antagonisten zur Behandlung von Wunden
CA2065375A1 (en) * 1989-08-21 1991-02-22 Richard J. Sharpe Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists

Also Published As

Publication number Publication date
EP0522226B1 (de) 1997-09-10
IT1249678B (it) 1995-03-09
JPH0525047A (ja) 1993-02-02
ITRM910519A1 (it) 1993-01-12
ITRM910519A0 (it) 1991-07-12
EP0522226A1 (de) 1993-01-13
ATE157872T1 (de) 1997-09-15

Similar Documents

Publication Publication Date Title
EP0371728B1 (de) Wässrige Augenlösung und Verfahren zur Konservierung derselben
RU2004134733A (ru) Агенты, которые регулируют, ингибируют или модулируют активность и/или экспрессию факторов роста соединительной ткани (фрст), в качестве уникальных средств для снижения внутриглазного давления и лечения глаукоматозных ретинопатий/оптических невропатий
US5215991A (en) Combination of selective alpha-adrenergic agonists and Na+ /H+ ex
ATE265856T1 (de) Augenlösung mit tetracyclin für behandlung von trockenen augen
CA2339093A1 (en) Cholinergic agents in the treatment of presbyopia
US4594091A (en) Borate algaecide and fungicide
DE69127619D1 (de) Ketanserin enthaltende Augentropfen zur Behandlung von intraokularem Druck
DE69521686D1 (de) Ophtalmische zubereitung niedriger viskosität
US4642234A (en) Disinfection of contact lenses
TR199901468T2 (xx) Alfa-2 adrenosept�r agonistleri olarak yararl� guanidinil heterosikl bile�ikleri.
US5131938A (en) Borate algaecide and fungicide
EP0114333B1 (de) Pharmazeutische Zusammensetzung
US6440411B2 (en) Ophthalmic product colored with blue alga extract
US4390542A (en) Method for inhibiting contraction of opthalmic wounds or incisions
CA1246457A (en) Method of treating cardiac insufficiency
CA2047783C (en) Stable solution of sodium hypochlorite
RU2009120545A (ru) Модуляторы связывания pai-1 для лечения глазных болезней
ATE181829T1 (de) Gaba-erge modulation des augenwachstums
SE9403831D0 (sv) A storage stable water solution for infusion I
US5256660A (en) Synthetic buffer composition for clinical use
HU209538B (en) Set and cleaning composition for treating contactlenses
EP1522321B1 (de) Verfahren zur Desinfektion und/oder Reinigung von Kontaktlinsen unter Verwendung einer wässrigen Lösung enthaltend wenigstens einen Bestandteil der Aloe Vera Pflanze
Langley et al. Effect of atropine and acetylcholine on nerve stimulated output of noradrenaline and dopamine-beta-hydroxylase from isolated rabbit and guinea pig hearts
Kaufman et al. Therapy of experimental herpes simplex keratitis
JPS6452727A (en) Antiallergic eye drop

Legal Events

Date Code Title Description
8332 No legal effect for de